Picture

Questions?

+1-866-353-3335

SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare
Free Samples

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1469883

Cover Image

PUBLISHER: MarketsandMarkets | PRODUCT CODE: 1469883

Allergy Diagnostics Market by Product & Service (Consumables, Instruments (Immunoassay Analyzer, Luminometer), Services), Test Type (In Vivo (Skin Prick, Patch), In Vitro), Allergen (Food, Inhaled, Drug), End User, & Region - Global Forecast to 2029

PUBLISHED:
PAGES: 294 Pages
DELIVERY TIME: 1-2 business days
REQUEST FREE SAMPLE
REQUEST CUSTOMIZATION
SELECT AN OPTION
PDF (Single User License)
USD 4950
PDF (5-user License)
USD 6650
PDF (Corporate License)
USD 8150
PDF (Global License)
USD 10000

Add to Cart

Description

Table of Contents

The global Allergy Diagnostics market is projected to reach USD 9.8 billion by 2029 from USD 5.3 billion in 2024, at a CAGR of 11.0% during the forecast period. The growth of this market is majorly driven by rise in awareness program by government and associations, growing allergy research, and rise in innovative technologies for allergy diagnosis. However, a smaller number of allergists and poor implementation of allergy testing methods could restrain the growth of the Allergy Diagnostics market.

Scope of the Report
Years Considered for the Study2022-2029
Base Year2023
Forecast Period2024-2029
Units ConsideredValue (USD) Billion
SegmentsProduct & Service, Test Type, Allergen, and End User
Regions coveredNorth America, Europe, Asia Pacific, Latin America, and Middle East & Africa

"Consumables segment accounted for the highest market share in the Allergy Diagnostics market, by product & service, during the forecast period."

Based on product & service, the Allergy Diagnostics market is segmented into consumables, instruments, and services. In 2023, the consumables segment accounted for the largest share of the Allergy Diagnostics market. Growing prevalence of allergies including inhaled and food allergies and emergence of local players in in vivo test kits to drive the market of this segment during the forecast period. This segment is also anticipated to witness substantial growth over the projected period.

"In Vivo type of tests accounted for the larger market share in the Allergy Diagnostics market, by test type, during the forecast period."

The Allergy Diagnostics market is segmented into in vivo tests and in vitro tests based on test type. The in vivo tests segment accounted for the largest share of the Allergy Diagnostics market in 2023 and is also projected to acquire highest CAGR during the forecast period. The growth of in vivo test segment is majorly driven by the increase in demand for point-of care testing and growing awareness about allergic symptoms and need for getting tested.

"Hospital-based laboratories & clinics accounted for the highest CAGR during the forecast period."

Based on the end user, the Allergy Diagnostics market is segmented into diagnostic laboratories, hospital-based laboratories & clinics, academic research institutes, and other end users. In 2023, the hospital-based laboratories & clinics segment accounted for the largest share of the market. The clinics' significant end-user standing for in vivo allergy testing and their convenience in terms of allergy management and treatment options are the main reasons for their substantial market share.

"The North America segment accounted for the highest market share in the Allergy Diagnostics market, by region, during the forecast period."

Based on the region, the Allergy Diagnostics market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. North America region accounted for the largest share of the global Allergy Diagnostics market in 2023. This large share of North America is due to the growing incidence of food and respiratory allergies, rise in agreement for awareness between government and associations, and presence of major players in the region.

Breakdown of supply-side primary interviews by company type, designation, and region:

  • By Company Type: Tier 1 (20%), Tier 2 (45%), and Tier 3 (35%)
  • By Designation: C-level (30%), Director-level (20%), and Others (50%)
  • By Region: North America (36%), Asia- Pacific (27%), Europe (25%), and Latin America- (7%) and MEA-(5%)

Prominent companies include Thermo Fisher Scientific Inc., (US), Siemens Healthineers Ag (Germany), Danaher Corporation (US), Minaris Medical America, Inc. (US), Omega Diagnostics Group PLC (UK), bioMerieux SA (France), Romer Labs Division Holding (Austria), EUROIMMUN Medizinische Labordiagnostika AG (Germany), HollisterStier Allergy (US), Eurofins Scientific (Luxembourg), and Stallergenes Greer (UK).

Research Coverage

This research report categorizes the Allergy Diagnostics market by product & service, test type, allergen, end user, and region. The scope of the report covers detailed information regarding the major factors, such as drivers, restraints, challenges, and opportunities, influencing the growth of the Allergy Diagnostics market. A detailed analysis of the key industry players has been done to provide insights into their business overview, solutions, services; key strategies; Contracts, partnerships, and agreements. New product launches, mergers and acquisitions, and recent developments associated with the Allergy Diagnostics market. Competitive analysis of upcoming startups in the Allergy Diagnostics market ecosystem is covered in this report.

Key Benefits of Buying the Report:

The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall Allergy Diagnostics market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

The report provides insights on the following pointers:

  • Analysis of key drivers (global rise in prevalence and heavy economic burden of allergic illnesses, growing environmental pollution, and insurance coverage), restraints (high costs of analyzers and access is limited to healthcare services), opportunities (use of mHealth and integration of AI in allergy diagnosis), and challenges (a few number of allergists and challenges during diagnosis of allergy) influencing the growth of the Allergy Diagnostics market
  • Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product & service launches in the Allergy Diagnostics market.
  • Market Development: Comprehensive information about lucrative markets - the report analyses the Allergy Diagnostics market across varied regions.
  • Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the Allergy Diagnostics market
  • Competitive Assessment: In-depth assessment of market ranking, growth strategies, and service offerings of leading players like Thermo Fisher Scientific Inc., (US), Siemens Healthineers AG (Germany), Danaher (US), and Canon, Inc. (Japan) [Minaris Medical America, Inc. (US)], among others in the Allergy Diagnostics market strategies.
Show more
Product Code: MD 2955

TABLE OF CONTENTS

1 INTRODUCTION

  • 1.1 STUDY OBJECTIVES
  • 1.2 MARKET DEFINITION
  • 1.3 INCLUSIONS AND EXCLUSIONS
  • 1.4 MARKET SEGMENTATION
    • 1.4.1 MARKETS COVERED
    • 1.4.2 REGIONS COVERED
    • 1.4.3 YEARS CONSIDERED
    • 1.4.4 CURRENCY CONSIDERED
  • 1.5 MARKET STAKEHOLDERS
  • 1.6 SUMMARY OF CHANGES
  • 1.7 RECESSION IMPACT

2 RESEARCH METHODOLOGY

  • 2.1 RESEARCH DATA
    • FIGURE 1 ALLERGY DIAGNOSTICS MARKET: RESEARCH DESIGN METHODOLOGY
    • 2.1.1 SECONDARY DATA
      • 2.1.1.1 Secondary sources
    • 2.1.2 PRIMARY DATA
    • TABLE 1 KEY DATA FROM PRIMARY SOURCES
    • FIGURE 2 KEY INDUSTRY INSIGHTS
      • 2.1.2.1 Breakdown of primary interviews
    • FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS
    • FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
    • FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY END USER, DESIGNATION, AND REGION
    • 2.1.3 MARKET SIZE ESTIMATION
    • FIGURE 6 BOTTOM-UP APPROACH: REVENUE-BASED APPROACH
      • 2.1.3.1 Growth forecast
      • 2.1.3.2 CAGR projections
    • FIGURE 7 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS
    • 2.1.4 TOP-DOWN APPROACH
    • FIGURE 8 ALLERGY DIAGNOSTICS MARKET: TOP-DOWN APPROACH
  • 2.2 MARKET BREAKDOWN AND DATA TRIANGULATION
    • FIGURE 9 DATA TRIANGULATION METHODOLOGY
  • 2.3 STUDY ASSUMPTIONS
    • TABLE 2 ALLERGY DIAGNOSTICS MARKET: IMPACT ANALYSIS
  • 2.4 RISK ASSESSMENT
    • TABLE 3 ALLERGY DIAGNOSTICS MARKET: RISK ASSESSMENT ANALYSIS
  • 2.5 RESEARCH LIMITATIONS
  • 2.6 RECESSION IMPACT ANALYSIS

3 EXECUTIVE SUMMARY

    • FIGURE 10 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2024 VS. 2029 (USD BILLION)
    • FIGURE 11 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2024 VS. 2029 (USD BILLION)
    • FIGURE 12 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2024 VS. 2029 (USD BILLION)
    • FIGURE 13 ALLERGY DIAGNOSTICS MARKET, BY END USER, 2024 VS. 2029 (USD BILLION)
    • FIGURE 14 REGIONAL SNAPSHOT OF ALLERGY DIAGNOSTICS MARKET

4 PREMIUM INSIGHTS

  • 4.1 ALLERGY DIAGNOSTICS MARKET OVERVIEW
    • FIGURE 15 INCREASING NUMBER OF GOVERNMENT INITIATIVES AND INVESTMENTS TO DRIVE MARKET
  • 4.2 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN AND COUNTRY (2023)
    • FIGURE 16 CHINA AND INHALED ALLERGENS ACCOUNTED FOR LARGEST MARKET SHARE IN 2023
  • 4.3 ALLERGY DIAGNOSTICS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
    • FIGURE 17 CHINA TO REGISTER HIGHEST GROWTH RATE DURING STUDY PERIOD
  • 4.4 ALLERGY DIAGNOSTICS MARKET: REGIONAL MIX
    • FIGURE 18 ASIA PACIFIC TO WITNESS FASTEST GROWTH DURING FORECAST PERIOD
  • 4.5 ALLERGY DIAGNOSTICS MARKET: DEVELOPED VS. EMERGING ECONOMIES
    • FIGURE 19 EMERGING ECONOMIES TO REGISTER HIGHER GROWTH RATES DURING FORECAST PERIOD

5 MARKET OVERVIEW

  • 5.1 INTRODUCTION
  • 5.2 MARKET DYNAMICS
    • FIGURE 20 ALLERGY DIAGNOSTICS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
    • 5.2.1 DRIVERS
      • 5.2.1.1 High incidence and heavy economic burden of allergic diseases
      • 5.2.1.2 Increasing awareness about allergies
      • 5.2.1.3 Rising environmental pollution levels
      • 5.2.1.4 Increased funding for allergy diagnostics
      • 5.2.1.5 Coverage of allergy diagnosis under health insurance schemes
    • 5.2.2 RESTRAINTS
      • 5.2.2.1 Premium cost of allergy diagnostic instruments
      • 5.2.2.2 Lack of adequate knowledge and poor implementation of allergy testing methods
      • 5.2.2.3 Limited access to healthcare services
    • 5.2.3 OPPORTUNITIES
      • 5.2.3.1 Use of mHealth in allergy diagnosis
      • 5.2.3.2 Integration of artificial intelligence in allergy diagnosis
    • 5.2.4 CHALLENGES
      • 5.2.4.1 Shortage of allergists and lack of training programs
      • 5.2.4.2 Diagnostic challenges in allergic patients
    • 5.2.5 TRENDS
      • 5.2.5.1 Rising use of reagent rental agreements and cost-per-test contracts
      • 5.2.5.2 Increasing use of molecular diagnostics and point-of-care allergy testing
  • 5.3 PRICING ANALYSIS
    • TABLE 4 AVERAGE SELLING PRICE TREND OF KEY PLAYERS, BY PRODUCT
    • TABLE 5 AVERAGE SELLING PRICE TREND, BY REGION
  • 5.4 PATENT ANALYSIS
    • FIGURE 21 PATENT ANALYSIS FOR ALLERGY DIAGNOSTIC PRODUCTS (JANUARY 2014-DECEMBER 2023)
  • 5.5 VALUE CHAIN ANALYSIS
    • FIGURE 22 VALUE CHAIN ANALYSIS: MAJOR VALUE ADDED DURING MANUFACTURING AND ASSEMBLY PHASES
  • 5.6 SUPPLY CHAIN ANALYSIS
    • FIGURE 23 ALLERGY DIAGNOSTICS MARKET: SUPPLY CHAIN ANALYSIS
  • 5.7 ECOSYSTEM ANALYSIS
    • FIGURE 24 ALLERGY DIAGNOSTICS MARKET: ECOSYSTEM/MARKET MAP
    • 5.7.1 ALLERGY DIAGNOSTICS MARKET: ROLE IN ECOSYSTEM
    • FIGURE 25 KEY PLAYERS IN ALLERGY DIAGNOSTICS MARKET
  • 5.8 PORTER'S FIVE FORCES ANALYSIS
    • TABLE 6 ALLERGY DIAGNOSTICS MARKET: PORTER'S FIVE FORCES ANALYSIS
    • 5.8.1 DEGREE OF COMPETITION
    • 5.8.2 BARGAINING POWER OF SUPPLIERS
    • 5.8.3 BARGAINING POWER OF BUYERS
    • 5.8.4 THREAT OF SUBSTITUTES
    • 5.8.5 THREAT OF NEW ENTRANTS
  • 5.9 REGULATORY ANALYSIS
    • 5.9.1 REGULATORY LANDSCAPE
      • 5.9.1.1 North America
        • 5.9.1.1.1 US
    • TABLE 7 US: CLASSIFICATION OF IMMUNOASSAY PRODUCTS
    • FIGURE 26 US: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
        • 5.9.1.1.2 Canada
    • FIGURE 27 CANADA: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
      • 5.9.1.2 Europe
    • TABLE 8 EUROPE: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
    • FIGURE 28 EUROPE: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
        • 5.9.1.2.1 Russia
    • TABLE 9 RUSSIA: CLASSIFICATION OF IN VITRO DIAGNOSTIC DEVICES
      • 5.9.1.3 Asia Pacific
        • 5.9.1.3.1 Japan
    • FIGURE 29 JAPAN: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
    • TABLE 10 JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
        • 5.9.1.3.2 China
    • TABLE 11 CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
        • 5.9.1.3.3 India
    • FIGURE 30 INDIA: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
        • 5.9.1.3.4 Indonesia
    • TABLE 12 INDONESIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
        • 5.9.1.3.5 South Korea
    • TABLE 13 SOUTH KOREA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
      • 5.9.1.4 Middle East & Africa
        • 5.9.1.4.1 Saudi Arabia
    • TABLE 14 SAUDI ARABIA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
      • 5.9.1.5 Latin America
        • 5.9.1.5.1 Mexico
    • FIGURE 31 MEXICO: REGULATORY PROCESS FOR IN-VIRTO DIAGNOSTIC DEVICES
    • TABLE 15 MEXICO: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS
        • 5.9.1.5.2 Brazil
    • FIGURE 32 BRAZIL: REGULATORY PROCESS FOR IN VITRO DIAGNOSTIC DEVICES
    • 5.9.2 LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 16 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 17 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 18 LATIN AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
    • TABLE 19 REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
  • 5.10 TRADE ANALYSIS
    • 5.10.1 EXPORT DATA FOR HS CODE 902750
    • TABLE 20 EXPORT DATA FOR HS CODE 902750, BY COUNTRY, 2019-2023 (USD MILLION)
    • 5.10.2 IMPORT DATA FOR HS CODE 902750
    • TABLE 21 IMPORT DATA FOR HS CODE 902750, BY COUNTRY, 2019-2023 (USD MILLION)
  • 5.11 TECHNOLOGY ANALYSIS
    • 5.11.1 ALLERGY DIAGNOSTICS MARKET: KEY TECHNOLOGIES
    • TABLE 22 KEY TECHNOLOGIES IN ALLERGY DIAGNOSTICS MARKET
    • 5.11.2 ALLERGY DIAGNOSTICS MARKET: COMPLEMENTARY TECHNOLOGIES
  • 5.12 KEY CONFERENCES AND EVENTS, 2024-2025
    • TABLE 23 ALLERGY DIAGNOSTICS MARKET: DETAILED LIST OF KEY CONFERENCES & EVENTS, JANUARY 2024-DECEMBER 2025
  • 5.13 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS' BUSINESSES
    • FIGURE 33 REVENUE SHIFT IN ALLERGY DIAGNOSTICS
  • 5.14 KEY STAKEHOLDERS & BUYING CRITERIA
    • 5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS
    • FIGURE 34 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF ALLERGY DIAGNOSTIC PRODUCTS
    • TABLE 24 INFLUENCE OF KEY STAKEHOLDERS ON BUYING PROCESS OF ALLERGY DIAGNOSTIC PRODUCTS
    • 5.14.2 KEY BUYING CRITERIA
    • FIGURE 35 KEY BUYING CRITERIA FOR ALLERGY DIAGNOSTIC PRODUCTS
    • TABLE 25 KEY BUYING CRITERIA FOR ALLERGY DIAGNOSTIC PRODUCTS

6 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE

  • 6.1 INTRODUCTION
    • TABLE 26 ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
  • 6.2 CONSUMABLES
    • 6.2.1 RECURRENT USE TO DRIVE MARKET
    • TABLE 27 ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 28 NORTH AMERICA: ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 29 EUROPE: ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 30 ASIA PACIFIC: ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 31 LATIN AMERICA: ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 32 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTIC CONSUMABLES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.3 INSTRUMENTS
    • TABLE 33 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 34 ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 35 NORTH AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 36 EUROPE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 37 ASIA PACIFIC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 38 LATIN AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 39 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.1 IMMUNOASSAY ANALYZERS
      • 6.3.1.1 High preference for testing to boost demand
    • TABLE 40 IMMUNOASSAY ANALYZERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 41 NORTH AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 42 EUROPE: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 43 ASIA PACIFIC: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 44 LATIN AMERICA: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 45 MIDDLE EAST & AFRICA: IMMUNOASSAY ANALYZERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.2 LUMINOMETERS
      • 6.3.2.1 Convenience and ease of use to drive market
    • TABLE 46 LUMINOMETERS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 47 NORTH AMERICA: LUMINOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 48 EUROPE: LUMINOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 49 ASIA PACIFIC: LUMINOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 50 LATIN AMERICA: LUMINOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 51 MIDDLE EAST & AFRICA: LUMINOMETERS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 6.3.3 OTHER INSTRUMENTS
    • TABLE 52 ALLERGY DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 53 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 54 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 55 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 56 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 57 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR OTHER INSTRUMENTS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 6.4 SERVICES
    • 6.4.1 RISING NEED TO ENSURE EFFECTIVE UTILIZATION OF ALLERGY DIAGNOSTIC PRODUCTS TO SUPPORT MARKET GROWTH
    • TABLE 58 ALLERGY DIAGNOSTIC SERVICES MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 59 NORTH AMERICA: ALLERGY DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 60 EUROPE: ALLERGY DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 61 ASIA PACIFIC: ALLERGY DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 62 LATIN AMERICA: ALLERGY DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 63 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTIC SERVICES MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

7 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE

  • 7.1 INTRODUCTION
    • TABLE 64 ADVANTAGES AND LIMITATIONS OF ALLERGY TESTS
    • TABLE 65 ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
  • 7.2 IN VIVO TESTS
    • TABLE 66 ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 67 ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 68 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 69 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 70 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 71 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 72 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • 7.2.1 SKIN PRICK TESTS
      • 7.2.1.1 Most widely preferred in vivo allergy tests
    • TABLE 73 SKIN PRICK TESTS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 74 NORTH AMERICA: SKIN PRICK TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 75 EUROPE: SKIN PRICK TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 76 ASIA PACIFIC: SKIN PRICK TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 77 LATIN AMERICA: SKIN PRICK TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 78 MIDDLE EAST & AFRICA: SKIN PRICK TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 7.2.2 PATCH TESTS
      • 7.2.2.1 Rapid diagnosis of contact dermatitis to boost demand
    • TABLE 79 PATCH TESTS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 80 NORTH AMERICA: PATCH TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 81 EUROPE: PATCH TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 82 ASIA PACIFIC: PATCH TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 83 LATIN AMERICA: PATCH TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 84 MIDDLE EAST & AFRICA: PATCH TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • 7.2.3 OTHER IN VIVO TESTS
    • TABLE 85 OTHER IN VIVO TESTS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 86 NORTH AMERICA: OTHER IN VIVO TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 87 EUROPE: OTHER IN VIVO TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 88 ASIA PACIFIC: OTHER IN VIVO TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 89 LATIN AMERICA: OTHER IN VIVO TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 90 MIDDLE EAST & AFRICA: OTHER IN VIVO TESTS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 7.3 IN VITRO TESTS
    • 7.3.1 ABILITY TO IDENTIFY ALLERGEN-SPECIFIC IGE MOLECULES IN A PATIENT'S SERUM TO DRIVE MARKET
    • TABLE 91 ALLERGY DIAGNOSTICS MARKET FOR IN VITRO TESTS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 92 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VITRO TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 93 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR IN VITRO TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 94 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR IN VITRO TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 95 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VITRO TESTS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 96 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR IN VITRO TESTS, BY COUNTRY, 2022-2029 (USD MILLION)

8 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN

  • 8.1 INTRODUCTION
    • TABLE 97 ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
  • 8.2 INHALED ALLERGENS
    • 8.2.1 HIGH INCIDENCE OF ASTHMA TO PROPEL MARKET
    • TABLE 98 INHALED ALLERGEN DIAGNOSTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 99 NORTH AMERICA: INHALED ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 100 EUROPE: INHALED ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 101 ASIA PACIFIC: INHALED ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 102 LATIN AMERICA: INHALED ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 103 MIDDLE EAST & AFRICA: INHALED ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.3 FOOD ALLERGENS
    • 8.3.1 HIGH PREVALENCE AMONG CHILDREN TO SUPPORT MARKET GROWTH
    • TABLE 104 SPECIFIC FOOD-INDUCED ALLERGIC CONDITIONS
    • TABLE 105 FOOD ALLERGEN DIAGNOSTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 106 NORTH AMERICA: FOOD ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 107 EUROPE: FOOD ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 108 ASIA PACIFIC: FOOD ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 109 LATIN AMERICA: FOOD ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 110 MIDDLE EAST & AFRICA: FOOD ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.4 DRUG ALLERGENS
    • 8.4.1 INCREASING INCIDENCE OF DRUG ALLERGIES TO DRIVE MARKET
    • TABLE 111 DRUG ALLERGEN DIAGNOSTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 112 NORTH AMERICA: DRUG ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 113 EUROPE: DRUG ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 114 ASIA PACIFIC: DRUG ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 115 LATIN AMERICA: DRUG ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 116 MIDDLE EAST & AFRICA: DRUG ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
  • 8.5 OTHER ALLERGENS
    • TABLE 117 OTHER ALLERGEN DIAGNOSTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 118 NORTH AMERICA: OTHER ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 119 EUROPE: OTHER ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 120 ASIA PACIFIC: OTHER ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 121 LATIN AMERICA: OTHER ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 122 MIDDLE EAST & AFRICA: OTHER ALLERGEN DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)

9 ALLERGY DIAGNOSTICS MARKET, BY END USER

  • 9.1 INTRODUCTION
    • TABLE 123 ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 9.2 HOSPITAL-BASED LABORATORIES & CLINICS
    • 9.2.1 MORE ACCESSIBLE TO PATIENTS AND OFFER RAPID RESULTS
    • TABLE 124 ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES & CLINICS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 125 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 126 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 127 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 128 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 129 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR HOSPITAL-BASED LABORATORIES & CLINICS, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.3 DIAGNOSTIC LABORATORIES
    • 9.3.1 MAJOR END USERS OF ALLERGY DIAGNOSTIC PRODUCTS
    • TABLE 130 ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 131 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 132 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 133 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 134 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 135 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR DIAGNOSTIC LABORATORIES, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.4 ACADEMIC RESEARCH INSTITUTES
    • 9.4.1 RISING NUMBER OF INSTITUTES OFFERING ALLERGY TESTING TRAINING TO SUPPORT MARKET GROWTH
    • TABLE 136 ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 137 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 138 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 139 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 140 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 141 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY COUNTRY, 2022-2029 (USD MILLION)
  • 9.5 OTHER END USERS
    • TABLE 142 ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 143 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 144 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 145 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 146 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 147 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR OTHER END USERS, BY COUNTRY, 2022-2029 (USD MILLION)

10 ALLERGY DIAGNOSTICS MARKET, BY REGION

  • 10.1 INTRODUCTION
    • TABLE 148 ALLERGY DIAGNOSTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
  • 10.2 NORTH AMERICA
    • 10.2.1 NORTH AMERICA: RECESSION IMPACT
    • FIGURE 36 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET SNAPSHOT
    • TABLE 149 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 150 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 151 NORTH AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 152 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 153 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 154 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 155 NORTH AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.2.2 US
      • 10.2.2.1 US to dominate North American allergy diagnostics market
    • TABLE 156 US: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 157 US: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 158 US: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 159 US: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 160 US: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 161 US: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • TABLE 162 US: ALLERGY DIAGNOSTICS MARKET, BY NUMBER OF PATIENTS BEING TESTED. 2018-2029 (MILLION)
    • 10.2.3 CANADA
      • 10.2.3.1 Rising funding activities in allergy diagnostics to drive market
    • TABLE 163 CANADA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 164 CANADA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 165 CANADA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 166 CANADA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 167 CANADA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 168 CANADA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.3 EUROPE
    • 10.3.1 EUROPE: RECESSION IMPACT
    • TABLE 169 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 170 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 171 EUROPE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 172 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 173 EUROPE: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 174 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 175 EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.2 GERMANY
      • 10.3.2.1 Germany to hold largest market share in Europe
    • TABLE 176 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 177 GERMANY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 178 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 179 GERMANY: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 180 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 181 GERMANY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.3 UK
      • 10.3.3.1 Increasing prevalence of food anaphylaxis to support market growth
    • TABLE 182 UK: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 183 UK: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 184 UK: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 185 UK: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 186 UK: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 187 UK: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.4 FRANCE
      • 10.3.4.1 Increasing reimbursements for allergy testing to support market growth
    • TABLE 188 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 189 FRANCE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 190 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 191 FRANCE: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 192 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 193 FRANCE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.5 ITALY
      • 10.3.5.1 Presence of allergy diagnostic organizations to support research & demand for products
    • TABLE 194 ITALY: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 195 ITALY: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 196 ITALY: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 197 ITALY: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 198 ITALY: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 199 ITALY: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.6 SPAIN
      • 10.3.6.1 Government initiatives and healthcare infrastructural development to drive market
    • TABLE 200 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 201 SPAIN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 202 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 203 SPAIN: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 204 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 205 SPAIN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.3.7 REST OF EUROPE
    • TABLE 206 REST OF EUROPE: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 207 REST OF EUROPE: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 208 REST OF EUROPE: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 209 REST OF EUROPE: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 210 REST OF EUROPE: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 211 REST OF EUROPE: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.4 ASIA PACIFIC
    • 10.4.1 ASIA PACIFIC: RECESSION IMPACT
    • FIGURE 37 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET SNAPSHOT
    • TABLE 212 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 213 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 214 ASIA PACIFIC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 215 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 216 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 217 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 218 ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.2 CHINA
      • 10.4.2.1 China to hold largest market share in APAC
    • TABLE 219 CHINA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 220 CHINA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 221 CHINA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 222 CHINA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 223 CHINA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 224 CHINA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.3 JAPAN
      • 10.4.3.1 Increasing prevalence of allergies among children to propel demand for allergy diagnostics
    • TABLE 225 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 226 JAPAN: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 227 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 228 JAPAN: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 229 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 230 JAPAN: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.4 INDIA
      • 10.4.4.1 Limited awareness regarding allergy management to limit market growth
    • TABLE 231 INDIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 232 INDIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 233 INDIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 234 INDIA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 235 INDIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 236 INDIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.5 AUSTRALIA
      • 10.4.5.1 High prevalence of food allergies to drive market
    • TABLE 237 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 238 AUSTRALIA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 239 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 240 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 241 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 242 AUSTRALIA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.4.6 REST OF ASIA PACIFIC
    • TABLE 243 REST OF ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 244 REST OF ASIA PACIFIC: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 245 REST OF ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 246 REST OF ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 247 REST OF ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 248 REST OF ASIA PACIFIC: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.5 LATIN AMERICA
    • 10.5.1 LATIN AMERICA: RECESSION IMPACT
    • TABLE 249 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY COUNTRY, 2022-2029 (USD MILLION)
    • TABLE 250 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 251 LATIN AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 252 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 253 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 254 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 255 LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.5.2 BRAZIL
      • 10.5.2.1 Brazil to hold largest market share in Latin America
    • TABLE 256 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 257 BRAZIL: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 258 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 259 BRAZIL: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 260 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 261 BRAZIL: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.5.3 MEXICO
      • 10.5.3.1 Growing focus on awareness training programs to boost demand
    • TABLE 262 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 263 MEXICO: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 264 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 265 MEXICO: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 266 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 267 MEXICO: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.5.4 REST OF LATIN AMERICA
    • TABLE 268 REST OF LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 269 REST OF LATIN AMERICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 270 REST OF LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 271 REST OF LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 272 REST OF LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 273 REST OF LATIN AMERICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
  • 10.6 MIDDLE EAST & AFRICA
    • 10.6.1 MIDDLE EAST & AFRICA: RECESSION IMPACT
    • TABLE 274 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY REGION, 2022-2029 (USD MILLION)
    • TABLE 275 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 276 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 277 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 278 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 279 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 280 MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.6.2 GCC COUNTRIES
      • 10.6.2.1 Rising healthcare spending to drive market
    • TABLE 281 GCC COUNTRIES: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 282 GCC COUNTRIES: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 283 GCC COUNTRIES: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 284 GCC COUNTRIES: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 285 GCC COUNTRIES: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 286 GCC COUNTRIES: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)
    • 10.6.3 REST OF MIDDLE EAST & AFRICA
    • TABLE 287 REST OF MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY PRODUCT & SERVICE, 2022-2029 (USD MILLION)
    • TABLE 288 REST OF MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS INSTRUMENTS MARKET, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 289 REST OF MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY TEST TYPE, 2022-2029 (USD MILLION)
    • TABLE 290 REST OF MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET FOR IN VIVO TESTS, BY TYPE, 2022-2029 (USD MILLION)
    • TABLE 291 REST OF MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY ALLERGEN, 2022-2029 (USD MILLION)
    • TABLE 292 REST OF MIDDLE EAST & AFRICA: ALLERGY DIAGNOSTICS MARKET, BY END USER, 2022-2029 (USD MILLION)

11 COMPETITIVE LANDSCAPE

  • 11.1 OVERVIEW
  • 11.2 STRATEGIES ADOPTED BY KEY PLAYERS
    • TABLE 293 OVERVIEW OF STRATEGIES DEPLOYED BY KEY ALLERGY DIAGNOSTICS COMPANIES
  • 11.3 REVENUE ANALYSIS
    • FIGURE 38 REVENUE ANALYSIS FOR KEY COMPANIES IN ALLERGY DIAGNOSTICS MARKET, 2019-2023 (USD MILLION)
  • 11.4 MARKET SHARE ANALYSIS
    • FIGURE 39 ALLERGY DIAGNOSTICS MARKET SHARE ANALYSIS, BY KEY PLAYER (2023)
    • TABLE 294 ALLERGY DIAGNOSTICS MARKET: DEGREE OF COMPETITION
  • 11.5 BRAND/PRODUCT COMPARISON
    • FIGURE 40 ALLERGY DIAGNOSTICS MARKET: BRAND COMPARISON FOR IMMUNOASSAY ANALYZERS, BY KEY PLAYER
  • 11.6 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023
    • 11.6.1 STARS
    • 11.6.2 EMERGING LEADERS
    • 11.6.3 PERVASIVE PLAYERS
    • 11.6.4 PARTICIPANTS
    • FIGURE 41 ALLERGY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023
    • 11.6.5 COMPANY FOOTPRINT ANALYSIS
    • FIGURE 42 ALLERGY DIAGNOSTICS MARKET: COMPANY FOOTPRINT
    • TABLE 295 ALLERGY DIAGNOSTICS MARKET: PRODUCT & SERVICE FOOTPRINT
    • TABLE 296 ALLERGY DIAGNOSTICS MARKET: REGIONAL FOOTPRINT
    • TABLE 297 ALLERGY DIAGNOSTICS MARKET: TEST TYPE FOOTPRINT
    • TABLE 298 ALLERGY DIAGNOSTICS MARKET: ALLERGENS FOOTPRINT
  • 11.7 COMPETITIVE EVALUATION MATRIX: STARTUPS/SMES, 2023
    • 11.7.1 PROGRESSIVE COMPANIES
    • 11.7.2 RESPONSIVE COMPANIES
    • 11.7.3 DYNAMIC COMPANIES
    • 11.7.4 STARTING BLOCKS
    • FIGURE 43 ALLERGY DIAGNOSTICS MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023
    • 11.7.5 COMPETITIVE BENCHMARKING
    • TABLE 299 ALLERGY DIAGNOSTICS MARKET: DETAILED LIST OF KEY STARTUPS/SMES
    • TABLE 300 PRODUCT & SERVICE FOOTPRINT (STARTUPS/SMES)
    • TABLE 301 REGIONAL FOOTPRINT (STARTUPS/SMES)
    • TABLE 302 COMPANY FOOTPRINT (STARTUPS/SMES)
  • 11.8 VALUATION AND FINANCIAL METRICS OF ALLERGY DIAGNOSTICS VENDORS
    • FIGURE 44 EV/EBITDA OF KEY VENDORS
    • FIGURE 45 EV/REV OF KEY VENDORS
    • FIGURE 46 BETA (5 YEARS) OF KEY VENDORS
    • FIGURE 47 1 YEAR PRICE TOTAL RETURN OF KEY VENDORS
  • 11.9 COMPETITIVE SCENARIO
    • 11.9.1 PRODUCT LAUNCHES & APPROVALS
    • TABLE 303 ALLERGY DIAGNOSTICS MARKET: PRODUCT LAUNCHES & APPROVALS, JANUARY 2020-MARCH 2024
    • 11.9.2 DEALS
    • TABLE 304 ALLERGY DIAGNOSTICS MARKET: DEALS, JANUARY 2020-MARCH 2024
    • 11.9.3 EXPANSIONS
    • TABLE 305 ALLERGY DIAGNOSTICS MARKET: EXPANSIONS, JANUARY 2020-MARCH 2024

12 COMPANY PROFILES

  • (Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))**
  • 12.1 KEY PLAYERS
    • 12.1.1 DANAHER CORPORATION
    • TABLE 306 DANAHER CORPORATION: COMPANY OVERVIEW
    • FIGURE 48 DANAHER CORPORATION: COMPANY SNAPSHOT (2023)
    • TABLE 307 DANAHER CORPORATION: PRODUCTS OFFERED
    • 12.1.2 THERMO FISHER SCIENTIFIC INC.
    • TABLE 308 THERMO FISHER SCIENTIFIC INC.: COMPANY OVERVIEW
    • FIGURE 49 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2023)
    • TABLE 309 THERMO FISHER SCIENTIFIC INC.: PRODUCTS OFFERED
    • TABLE 310 THERMO FISHER SCIENTIFIC INC.: PRODUCT LAUNCHES & APPROVALS
    • TABLE 311 THERMO FISHER SCIENTIFIC INC.: DEALS
    • 12.1.3 CANON, INC. (MINARIS MEDICAL AMERICA, INC.)
    • TABLE 312 CANON, INC. (MINARIS MEDICAL AMERICA, INC.): COMPANY OVERVIEW
    • FIGURE 50 CANON, INC. (MINARIS MEDICAL AMERICA, INC.): COMPANY SNAPSHOT (2023)
    • TABLE 313 CANON, INC. (MINARIS MEDICAL AMERICA, INC.): PRODUCTS OFFERED
    • TABLE 314 CANON, INC. (MINARIS MEDICAL AMERICA, INC.): DEALS
    • 12.1.4 SIEMENS HEALTHINEERS AG
    • TABLE 315 SIEMENS HEALTHINEERS AG: COMPANY OVERVIEW
    • FIGURE 51 SIEMENS HEALTHINEERS AG: COMPANY SNAPSHOT (2023)
    • TABLE 316 SIEMENS HEALTHINEERS AG: PRODUCTS OFFERED
    • 12.1.5 EUROFINS SCIENTIFIC
    • TABLE 317 EUROFINS SCIENTIFIC: COMPANY OVERVIEW
    • FIGURE 52 EUROFINS SCIENTIFIC: COMPANY SNAPSHOT (2023)
    • TABLE 318 EUROFINS SCIENTIFIC: PRODUCTS OFFERED
    • TABLE 319 EUROFINS SCIENTIFIC: EXPANSIONS
    • 12.1.6 REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG)
    • TABLE 320 REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG): COMPANY OVERVIEW
    • FIGURE 53 REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG): COMPANY SNAPSHOT (2023)
    • TABLE 321 REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG): PRODUCTS OFFERED
    • TABLE 322 REVVITY, INC. (EUROIMMUN MEDIZINISCHE LABORDIAGNOSTIKA AG): DEALS
    • 12.1.7 BIOMERIEUX SA
    • TABLE 323 BIOMERIEUX SA: COMPANY OVERVIEW
    • FIGURE 54 BIOMERIEUX SA: COMPANY SNAPSHOT (2022)
    • TABLE 324 BIOMERIEUX SA: PRODUCTS OFFERED
    • 12.1.8 STALLERGENES GREER LTD.
    • TABLE 325 STALLERGENES GREER LTD.: COMPANY OVERVIEW
    • TABLE 326 STALLERGENES GREER LTD.: PRODUCTS OFFERED
    • TABLE 327 STALLERGENES GREER LTD.: DEALS
    • 12.1.9 ROMER LABS DIVISION HOLDING GMBH
    • TABLE 328 ROMER LABS DIVISION HOLDING GMBH: COMPANY OVERVIEW
    • FIGURE 55 ROMER LABS DIVISION HOLDING GMBH: COMPANY SNAPSHOT (2022)
    • TABLE 329 ROMER LABS DIVISION HOLDING GMBH: PRODUCTS OFFERED
    • TABLE 330 ROMER LABS DIVISION HOLDING GMBH: DEALS
    • 12.1.10 HOLLISTERSTIER ALLERGY
    • TABLE 331 HOLLISTERSTIER ALLERGY: COMPANY OVERVIEW
    • FIGURE 56 JUBILANT PHARMA LIMITED: COMPANY SNAPSHOT (2022)
    • TABLE 332 HOLLISTERSTIER ALLERGY: PRODUCTS OFFERED
    • 12.1.11 OMEGA DIAGNOSTICS GROUP PLC
    • TABLE 333 OMEGA DIAGNOSTICS GROUP PLC: COMPANY OVERVIEW
    • FIGURE 57 OMEGA DIAGNOSTICS GROUP PLC: COMPANY SNAPSHOT (2023)
    • TABLE 334 OMEGA DIAGNOSTICS GROUP PLC: PRODUCTS OFFERED
  • 12.2 OTHER PLAYERS
    • 12.2.1 HOB BIOTECH GROUP CORP., LTD.
    • TABLE 335 HOB BIOTECH GROUP CORP., LTD.: COMPANY OVERVIEW
    • 12.2.2 HYCOR BIOMEDICAL
    • TABLE 336 HYCOR BIOMEDICAL: COMPANY OVERVIEW
    • 12.2.3 LINCOLN DIAGNOSTICS, INC.
    • TABLE 337 LINCOLN DIAGNOSTICS, INC.: COMPANY OVERVIEW
    • 12.2.4 R-BIOPHARM AG
    • TABLE 338 R-BIOPHARM AG: COMPANY OVERVIEW
    • 12.2.5 ASTRA BIOTECH GMBH
    • TABLE 339 ASTRA BIOTECH GMBH: COMPANY OVERVIEW
    • 12.2.6 ERBA GROUP
    • TABLE 340 ERBA GROUP: COMPANY OVERVIEW
    • 12.2.7 AESKU.GROUP GMBH
    • TABLE 341 AESKU.GROUP GMBH: COMPANY OVERVIEW
    • 12.2.8 ACON LABORATORIES, INC.
    • TABLE 342 ACON LABORATORIES, INC.: COMPANY OVERVIEW
    • 12.2.9 ALCIT INDIA PVT. LTD.
    • TABLE 343 ALCIT INDIA PVT. LTD.: COMPANY OVERVIEW
    • 12.2.10 BIOPANDA REAGENTS LTD.
    • TABLE 344 BIOPANDA REAGENTS LTD.: COMPANY OVERVIEW
    • 12.2.11 BIOSIDE S.R.L.
    • TABLE 345 BIOSIDE S.R.L.: COMPANY OVERVIEW
    • 12.2.12 CREATIVE DIAGNOSTIC MEDICARE PVT. LTD.
    • TABLE 346 CREATIVE DIAGNOSTIC MEDICARE PVT. LTD.: COMPANY OVERVIEW
    • 12.2.13 DST DIAGNOSTISCHE SYSTEME & TECHNOLOGIEN GMBH
    • TABLE 347 DST DIAGNOSTISCHE SYSTEME & TECHNOLOGIEN GMBH: COMPANY OVERVIEW
    • 12.2.14 DR. FOOKE LABORATORIEN GMBH
    • TABLE 348 DR. FOOKE LABORATORIEN GMBH: COMPANY OVERVIEW
  • *Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

13 APPENDIX

  • 13.1 DISCUSSION GUIDE
  • 13.2 KNOWLEDGESTORE: MARKETSANDMARKETS' SUBSCRIPTION PORTAL
  • 13.3 CUSTOMIZATION OPTIONS
  • 13.4 RELATED REPORTS
  • 13.5 AUTHOR DETAILS
Show more
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Contact Us +1-866-353-3335
Hi, how can we help?
Contact us!